Block listing Interim Review

Summary by AI ^BETAClose X

Tate & Lyle PLC has reported its six-monthly return for the Tate & Lyle Sharesave Plan covering the period from July 1, 2025, to December 31, 2025. The plan began with a balance of 286,445 unallotted securities, and during the period, 1,902 securities were issued or allotted. This leaves a remaining balance of 284,543 unallotted securities at the end of the period. The total number of shares in issue for Tate & Lyle PLC at the close of this period stands at 476,741,354.

Disclaimer*

Tate & Lyle PLC

07 January 2026

BLOCK LISTING SIX MONTHLY RETURN

Date: 7 JANUARY 2026

Name of applicant:		TATE & LYLE PLC
Name of scheme:		TATE & LYLE SHARESAVE PLAN
Period of return:	From:	1 JULY 2025	To:	31 DECEMBER 2025
Balance of unallotted securities under scheme(s) from previous return:		286,445
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		0
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		1,902
Equals: Balance under scheme(s) not yet issued/allotted at end of period:		284,543
Total number of shares in issue at the end of the period:		476,741,354

Name of contact:	MATTHEW JOY COMPANY SECRETARY
Telephone number of contact:	020 7257 2100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END